FDA NDC Directory · JSON-LD · Markdown

Rinvoq

NDC 0074-1043 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nameUpadacitinib
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211675
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsUPADACITINIB (45 mg/1)
Marketing started20190816
Package count2

External sources

Source: openFDA. Public-domain (CC0).